Harrow, Inc. Files 8-K: Officer/Director Changes & Compensation
Ticker: HROW · Form: 8-K · Filed: Oct 6, 2025 · CIK: 1360214
| Field | Detail |
|---|---|
| Company | Harrow, INC. (HROW) |
| Form Type | 8-K |
| Filed Date | Oct 6, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-departure, director-election, compensation
Related Tickers: HROW
TL;DR
Harrow Inc. 8-K: Exec shakeup, new board members, and comp plan updates filed Oct 6.
AI Summary
On October 6, 2025, Harrow, Inc. filed an 8-K report detailing the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits.
Why It Matters
Changes in key personnel and compensation structures can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with updates to compensation, can introduce uncertainty about future leadership and strategic direction.
Key Players & Entities
- HARROW, INC. (company) — Filer
- Harrow Health, Inc. (company) — Former Company Name
- Imprimis Pharmaceuticals, Inc. (company) — Former Company Name
- Transdel Pharmaceuticals Inc (company) — Former Company Name
FAQ
What specific items are covered in Harrow, Inc.'s 8-K filing dated October 6, 2025?
The filing covers the departure of certain officers and directors, the election of directors, and compensatory arrangements for certain officers, as well as Regulation FD disclosures and financial statements and exhibits.
What is Harrow, Inc.'s Central Index Key (CIK)?
Harrow, Inc.'s CIK is 0001360214.
What is Harrow, Inc.'s Standard Industrial Classification (SIC) code?
Harrow, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
When was Harrow, Inc. previously known as Harrow Health, Inc.?
Harrow, Inc. was formerly known as Harrow Health, Inc. as of December 28, 2018.
What is Harrow, Inc.'s business address?
Harrow, Inc.'s business address is 1A Burton Hills Blvd, Suite 200, Nashville, TN.
Filing Stats: 600 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-10-06 07:23:49
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share HROW The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-25-017007.txt ( ) — 283KB
- hrow-20251006.xsd (EX-101.SCH) — 4KB
- hrow-20251006_def.xml (EX-101.DEF) — 26KB
- hrow-20251006_lab.xml (EX-101.LAB) — 36KB
- hrow-20251006_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HARROW, INC. Dated: October 6, 2025 By: /s/ Andrew R. Boll Andrew R. Boll President and Chief Financial Officer